Chimera Investment CORP
Market Movers (8-K)
NYSE
Chimera Investment Corporation announced the results of its 2026 annual meeting, including the election of three Class I Directors and the ratification of its independent auditor.
NYSE
Chimera Investment Corporation announced its second quarter 2026 common stock dividend of $0.45 per share, maintaining its previously stated expectation.
NYSE
Chimera Investment Corporation announced the declaration of its second quarter 2026 cash dividends for its preferred stock series.
NYSE
Chimera Investment Corporation announced Q1 2026 financial results, reporting $46 million in Earnings Available for Distribution, covering its $0.45 dividend, while navigating market volatility.
Worse than expected
NYSE
Chimera Investment Corporation announced robust fourth-quarter and full-year 2025 financial results, driven by strategic transformation and an increased dividend.
Capital raise
Better than expected
NYSE
Chimera Investment Corporation announced an increase in its first quarter 2026 common stock dividend to $0.45 per share, up from $0.37 in the prior quarter.
Better than expected
Quarterly Earnings (10-Q)
NYSE
Chimera Investment Corporation reported a net loss of $43.9 million for the first quarter of 2026, a significant shift from the prior year's profit, driven by portfolio rebalancing and market conditions.
Worse than expected
NYSE
Chimera Investment Corporation reported a net loss for Q3 2025 and a decline in nine-month net income, while executing key strategic acquisitions and portfolio rebalancing.
Capital raise
Worse than expected
NYSE
Chimera Investment Corporation reported a significant quarter-over-quarter decline in Q2 2025 net income available to common shareholders, despite strategic acquisitions and increased Agency MBS allocation.
Worse than expected
Delay expected
Capital raise
NYSE
Chimera Investment Corporation announces positive Q1 2025 results, driven by unrealized gains on financial instruments and strategic portfolio management.
Better than expected
NYSE
Chimera Investment Corporation reports a significant increase in net income for the third quarter of 2024, driven by unrealized gains on financial instruments.
Better than expected
Capital raise
NYSE
Chimera Investment Corporation's second quarter 2024 results show a net income available to common shareholders of $33.9 million, or $0.42 per share, with a book value per common share of $21.27.
Worse than expected
Annual Reports (10-K)
NYSE
Chimera Investment Corporation's 2024 10-K filing reveals a year of strategic portfolio adjustments, including the acquisition of The Palisades Group, amid fluctuating interest rates and a challenging market environment.
Worse than expected
NYSE
Chimera Investment Corporation's 10-K filing details its capital stock structure, including common and preferred shares, and outlines key corporate governance provisions.
Insider Trading (Form 4)
NYSE
Director Susan Mills acquired 11,263 restricted stock units (RSUs) of Chimera Investment Corp. on June 11, 2026, with vesting scheduled for June 11, 2027, or the next annual stockholder meeting.
NYSE
Debra Still, a Director at Chimera Investment Corp, acquired 11,263 shares of common stock through the vesting of restricted stock units.
NYSE
Kevin Chavers, a Director at Chimera Investment Corp, acquired 11,263 shares of common stock through restricted stock units.
NYSE
Cynthia B. Walsh, a Director at Chimera Investment Corp, acquired 11,263 shares of common stock through restricted stock units.
NYSE
Director Brian Patrick Reilly acquired 11,263 restricted stock units (RSUs) of Chimera Investment Corp, with vesting scheduled for June 11, 2027, or the next annual stockholder meeting.
NYSE
Chimera Investment Corp Director Gerard Creagh acquired 11,263 shares of common stock through restricted stock units.
Proxy Statements (Def-14A)
NYSE
Chimera Investment Corporation announces its 2026 Annual Meeting of Stockholders to be held virtually on June 10, 2026, with key proposals including director elections and executive compensation.
NYSE
Chimera Investment Corporation's 2025 Annual Meeting will be held virtually on June 10, 2025, and stockholders are encouraged to vote on key proposals including the election of directors, executive compensation, and the ratification of Ernst & Young LLP as the independent auditor.
NYSE
Chimera Investment Corporation will hold its 2025 annual meeting of stockholders virtually on June 10, 2025, to elect directors, consider executive compensation, and ratify the appointment of Ernst & Young LLP as its independent accounting firm.
NYSE
DEFA14A: Chimera Investment Corporation Sets Date for 2024 Annual Meeting, Proxy Materials Available
Chimera Investment Corporation's annual meeting is scheduled for June 5, 2024, with proxy materials available for stockholders to review and vote on key proposals.
NYSE
Chimera Investment Corporation's 2024 annual meeting of stockholders will be held virtually on June 5, 2024, to elect directors, approve executive compensation, and ratify the appointment of Ernst & Young LLP as the independent accounting firm.
Schedule 13G - Passive Investments
NYSE
Vanguard Capital Management has disclosed beneficial ownership of 5% of Chimera Investment Corp's common stock as of June 30, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Chimera Investment Corp following an internal realignment.
NYSE
Thornburg Investment Management has reported a 6.34% beneficial ownership stake in Chimera Investment Corp's common stock.
NYSE
BlackRock, Inc. has filed an Amendment No. 13 to its Schedule 13G, disclosing a 9.2% beneficial ownership stake in Chimera Investment Corporation as of March 31, 2025.
NYSE
Thornburg Investment Management Inc. has disclosed a 6.12% beneficial ownership stake in Chimera Investment Corp., as reported in a recent Schedule 13G filing with the SEC.